Webinar Overview

Technological advances over the past 20 years have created the opportunity to assess, quantify, and routinely monitor research activities without a need to be physically present. Coronavirus has only intensified the discussion about whether to further implement digital technologies and processes into nonclinical studies.

A spirited panel discusses possible approaches, limitations, concerns, and benefits of using remote monitoring for nonclinical research.


Scientific Moderator and Presenters

Kevin McDorman, DVM, DAVCO, PhD
Executive Director, Global Pathology Services
Charles River

Elizabeth McInnes, BVSc, PhD, FRC Path, MRCVS, FIATP, MBA
Head of Toxicologic Pathology

Armando Irizarry Rovira, DVM, PhD, Diplomate, ACVP
Director of Investigative Toxicology, Nonclinical Study Management, and Pathology
Eli Lilly and Company


View the other webinars in the series:


We are focused on providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.